“…For instance, numerous studies have reported LDH as a prognostic biomarker for colorectal cancer [ 32 , 33 ], lung cancer [ 34 , 35 ], melanoma [ 36 , 37 ], renal cell cancer [ 38 , 39 ] and hepatocellular carcinoma [ 40 , 41 ]. Many studies have also shown that LDH is also a biomarker for malaria [ 42 , 43 , 44 ]. Moreover, LDH activity is an important clinical guide to the choice of chemotherapy and helps to identify whether a pleural effusion is benign or malignant [ 45 , 46 ].…”